A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer

NCT05859750 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: AK104
DRUG: AK104
DRUG: Gemcitabine
DRUG: Nab-Paclitaxel
DRUG: Liposomal Irinotecan, Oxaliplatin, 5-Fluorouracil/Calcium folinate
DRUG: Oxaliplatin + Irinotecan + 5-Fluorouracil/Leucovorin

Sponsor

Akeso